Structural basis of oncogenic activation caused by point mutations in the kinase domain of the MET proto-oncogene: modeling studies.

This publication has 47 references indexed in Scilit:

• The Multisubstrate Docking Site of the MET Receptor Is Dispensable for MET-mediated RAS Signaling and Cell Scattering
  Molecular Biology of the Cell, 1999
• Germline mutation of RET codon 883 in two cases of de novo MEN 2B
  Oncogene, 1997
• Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas
  Nature Genetics, 1997
• C-kit mutations and mast cell disorders. A model of activating mutations of growth factor receptors.
  Hematology and Cell Therapy, 1997
• Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis
  Nature, 1996
• Hepatocyte growth factor/scatter factor—Met signaling in tumorigenicity and invasion/metastasis
  Journal of Molecular Medicine, 1996
• Mutation of juxtamembrane tyrosine residue 1001 suppresses loss-of-function mutations of the met receptor in epithelial cells.
  Proceedings of the National Academy of Sciences, 1995
• Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor
  Nature, 1995
• Activation of RET as a Dominant Transforming Gene by Germline Mutations of MEN2A and MEN2B
  Science, 1995
• A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family
  Cell, 1994